Compare Globus Medical Inc. Class A Common Stock (GMED) vs Sony Group Corp (SONY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Sony Group Corp — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.99 (market cap $10.25B), while Sony Group Corp trades at $24.49 (market cap $142.29B). The key difference: Sony Group Corp is far larger — about 13.9× Globus Medical Inc. Class A Common Stock's market cap, and Sony Group Corp pays a 0.65% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Sony Group Corp for 96 Days on average.
| GMED | SONY | |
|---|---|---|
Market Cap | $10.25B | $142.29B |
Volume | 1,059,528 | 4,058,964 |
Sector | Health | Technology |
52-Week High | $96.82 | $30.26 |
52-Week Low | $58.33 | $19.32 |
Typical Hold Time | 0 Days | 96 Days |
Enterprise Value | $9.76B | $140.20B |
Dividend Yield | — | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Sony (SONY) trades at $24.33, up 0.29% on the day, with a bullish technical signal from moving averages and strong analyst support. Recent earnings show mixed quarterly results, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. The company reported robust operating cash flow of $2.32 trillion in 2025, though net income margin turned negative at -1.75% for 2026. Positive news highlights Sony's content strength and strategic positioning in AI and entertainment.
The outlook is cautiously optimistic, supported by analyst buy ratings and solid cash generation, but risks include profitability pressures and competitive threats. Investment appeal hinges on execution of content strategy and margin recovery, with Wall Street sentiment leaning bullish amid near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Sony Group Corp
Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →
